192 related articles for article (PubMed ID: 19909748)
1. Zinc mesoporphyrin induces rapid proteasomal degradation of hepatitis C nonstructural 5A protein in human hepatoma cells.
Hou W; Tian Q; Zheng J; Bonkovsky HL
Gastroenterology; 2010 May; 138(5):1909-19. PubMed ID: 19909748
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus NS5A promotes insulin resistance through IRS-1 serine phosphorylation and increased gluconeogenesis.
Parvaiz F; Manzoor S; Iqbal J; Sarkar-Dutta M; Imran M; Waris G
World J Gastroenterol; 2015 Nov; 21(43):12361-9. PubMed ID: 26604643
[TBL] [Abstract][Full Text] [Related]
3. Zinc mesoporphyrin induces rapid and marked degradation of the transcription factor Bach1 and up-regulates HO-1.
Hou W; Shan Y; Zheng J; Lambrecht RW; Donohue SE; Bonkovsky HL
Biochim Biophys Acta; 2008 Mar; 1779(3):195-203. PubMed ID: 18325350
[TBL] [Abstract][Full Text] [Related]
4. Daclatasvir-like inhibitors of NS5A block early biogenesis of hepatitis C virus-induced membranous replication factories, independent of RNA replication.
Berger C; Romero-Brey I; Radujkovic D; Terreux R; Zayas M; Paul D; Harak C; Hoppe S; Gao M; Penin F; Lohmann V; Bartenschlager R
Gastroenterology; 2014 Nov; 147(5):1094-105.e25. PubMed ID: 25046163
[TBL] [Abstract][Full Text] [Related]
5. Y-Box Binding Protein 1 Stabilizes Hepatitis C Virus NS5A via Phosphorylation-Mediated Interaction with NS5A To Regulate Viral Propagation.
Wang WT; Tsai TY; Chao CH; Lai BY; Wu Lee YH
J Virol; 2015 Nov; 89(22):11584-602. PubMed ID: 26355086
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of HCV replication by cyclophilin antagonists is linked to replication fitness and occurs by inhibition of membranous web formation.
Madan V; Paul D; Lohmann V; Bartenschlager R
Gastroenterology; 2014 May; 146(5):1361-72.e1-9. PubMed ID: 24486951
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C Virus Downregulates Ubiquitin-Conjugating Enzyme E2S Expression To Prevent Proteasomal Degradation of NS5A, Leading to Host Cells More Sensitive to DNA Damage.
Pham HT; Nguyen TTT; Nguyen LP; Han SS; Lim YS; Hwang SB
J Virol; 2019 Jan; 93(2):. PubMed ID: 30381483
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C Virus NS5A Protein Promotes the Lysosomal Degradation of Hepatocyte Nuclear Factor 1α via Chaperone-Mediated Autophagy.
Matsui C; Deng L; Minami N; Abe T; Koike K; Shoji I
J Virol; 2018 Jul; 92(13):. PubMed ID: 29695419
[TBL] [Abstract][Full Text] [Related]
9. Nonstructural 5A protein activates beta-catenin signaling cascades: implication of hepatitis C virus-induced liver pathogenesis.
Park CY; Choi SH; Kang SM; Kang JI; Ahn BY; Kim H; Jung G; Choi KY; Hwang SB
J Hepatol; 2009 Nov; 51(5):853-64. PubMed ID: 19726098
[TBL] [Abstract][Full Text] [Related]
10. Differential sensitivity of 5'UTR-NS5A recombinants of hepatitis C virus genotypes 1-6 to protease and NS5A inhibitors.
Li YP; Ramirez S; Humes D; Jensen SB; Gottwein JM; Bukh J
Gastroenterology; 2014 Mar; 146(3):812-821.e4. PubMed ID: 24262279
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus NS5A binds to the mRNA cap-binding eukaryotic translation initiation 4F (eIF4F) complex and up-regulates host translation initiation machinery through eIF4E-binding protein 1 inactivation.
George A; Panda S; Kudmulwar D; Chhatbar SP; Nayak SC; Krishnan HH
J Biol Chem; 2012 Feb; 287(7):5042-58. PubMed ID: 22184107
[TBL] [Abstract][Full Text] [Related]
12. Recombinant HCV variants with NS5A from genotypes 1-7 have different sensitivities to an NS5A inhibitor but not interferon-α.
Scheel TK; Gottwein JM; Mikkelsen LS; Jensen TB; Bukh J
Gastroenterology; 2011 Mar; 140(3):1032-42. PubMed ID: 21111742
[TBL] [Abstract][Full Text] [Related]
13. The oncogenic role of NS5A of hepatitis C virus is mediated by up-regulation of survivin gene expression in the hepatocellular cell through p53 and NF-κB pathways.
Jiang YF; He B; Li NP; Ma J; Gong GZ; Zhang M
Cell Biol Int; 2011 Dec; 35(12):1225-32. PubMed ID: 21612579
[TBL] [Abstract][Full Text] [Related]
14. Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication.
Wang C; Pflugheber J; Sumpter R; Sodora DL; Hui D; Sen GC; Gale M
J Virol; 2003 Apr; 77(7):3898-912. PubMed ID: 12634350
[TBL] [Abstract][Full Text] [Related]
15. NS5A--from obscurity to new target for HCV therapy.
Schmitz U; Tan SL
Recent Pat Antiinfect Drug Discov; 2008 Jun; 3(2):77-92. PubMed ID: 18673121
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C Virus Nonstructural Protein 5A Inhibits MG132-Induced Apoptosis of Hepatocytes in Line with NF-κB-Nuclear Translocation.
Jiang X; Kanda T; Wu S; Nakamoto S; Nakamura M; Sasaki R; Haga Y; Wakita T; Shirasawa H; Yokosuka O
PLoS One; 2015; 10(7):e0131973. PubMed ID: 26133378
[TBL] [Abstract][Full Text] [Related]
17. Andrographolide exerts anti-hepatitis C virus activity by up-regulating haeme oxygenase-1 via the p38 MAPK/Nrf2 pathway in human hepatoma cells.
Lee JC; Tseng CK; Young KC; Sun HY; Wang SW; Chen WC; Lin CK; Wu YH
Br J Pharmacol; 2014 Jan; 171(1):237-52. PubMed ID: 24117426
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity and resistance profile of samatasvir, a novel NS5A replication inhibitor of hepatitis C virus.
Bilello JP; Lallos LB; McCarville JF; La Colla M; Serra I; Chapron C; Gillum JM; Pierra C; Standring DN; Seifer M
Antimicrob Agents Chemother; 2014 Aug; 58(8):4431-42. PubMed ID: 24867983
[TBL] [Abstract][Full Text] [Related]
19. Dominant negative effect of wild-type NS5A on NS5A-adapted subgenomic hepatitis C virus RNA replicon.
Graziani R; Paonessa G
J Gen Virol; 2004 Jul; 85(Pt 7):1867-1875. PubMed ID: 15218171
[TBL] [Abstract][Full Text] [Related]
20. Proprotein convertase subtilisin/kexin type 9 inhibits hepatitis C virus replication through interacting with NS5A.
Li Z; Liu Q
J Gen Virol; 2018 Jan; 99(1):44-61. PubMed ID: 29235977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
